Julie Trulson
About Julie Trulson
Julie Trulson is the Vice President and Head of CMC, overseeing drug supply activities including process development, manufacturing, and distribution of clinical trial materials, with over 25 years of experience in biopharmaceutical development.
Julie Trulson - Professional Title and Responsibilities
Julie Trulson is the Vice President and Head of CMC at Asher Bio. She oversees drug supply activities across the portfolio, including process development, manufacturing, and distribution of clinical trial materials. Her role involves ensuring the seamless transition of drug products from development to clinical trials.
Julie Trulson's Experience and Background in Biopharmaceutical Development
Julie Trulson brings 25 years of experience in clinical and commercial stage biopharmaceutical development. She has worked within both biotechnology and pharmaceutical companies, applying her expertise to numerous drug development programs. Throughout her career, she has held pivotal roles that contributed significantly to advancing therapeutic options in the industry.
Julie Trulson's Role at Allogene
Immediately prior to joining Asher Bio, Julie Trulson built and led CMC cross-functional teams at Allogene. She was responsible for defining the allogenic cell therapy drug program strategy and delivering clinical supply. Her strategic leadership was instrumental in advancing Allogene's therapeutic initiatives.
Julie Trulson at OncoMed and Technical Leadership
At OncoMed, Julie Trulson held the position of Executive Director, Head of Process Development and Manufacturing. She managed a substantial pipeline of partnered clinical stage biologic candidates focused on oncology and immuno-oncology. Additionally, she played a key role as the global technical leader for Vectibix®, overseeing its US and ex-US launches, regulatory filings, and global post-launch submissions.
Julie Trulson's Education and Academic Background
Julie Trulson holds a Ph.D. in Chemistry from the University of California, Santa Cruz. She also earned a B.S. in Biochemistry from Washington State University. Her educational background has provided a strong foundation for her extensive career in biopharmaceutical development.